A Picture is Worth a Thousand Words: Coronary Artery Calcium Scores
Coronary Artery Calcium Scores
A CardioAdvocate Phenotype — 2026 Update: Landmark Evidence for CAC-Guided Prevention
The CAUGHT-CAD Trial (JAMA 2025) is the first randomized controlled trial to demonstrate that CAC-guided intervention reduces plaque progression. Combining knowledge of CAC score with lifestyle modification and statin therapy reduced plaque progression on CCTA compared to standard care (15.4 vs. 24.9 mm³). This is the evidence many have been waiting for.
Risk Calculators Miss the Mark: The CAUGHT-CAD trial enrolled 695 asymptomatic patients with family history of premature CAD — exactly the population where conventional risk calculators (like the PREVENT equations) underestimate risk. A randomized feasibility trial confirmed that CAC-guided statin allocation outperforms pooled cohort equations alone. Only imaging reveals what's really happening.
Expert Signal: Matthew Budoff continues to lead CAC progression research. The AHA just published a scientific statement on opportunistic CAC detection from non-cardiac CT scans.
Case Presentations
Patient A: "My Dad Had a Heart Attack at 50"
A 40-year-old healthy male presents to cardiology clinic. He has been diligent about exercising regularly due to his family history of heart disease.
Patient: "My dad died of a heart attack while playing tennis at age 61 and he was really fit. I don't want that to happen to me. So I got a Calcium CT scan and my CAC score is 32. Is that bad? It says it's just 'mild.'"
Cardiologist: "It's pretty low, so we don't need to worry about it yet. Let's keep an eye on it."
Patient: "But I went to the MESA website and plugged it into their Calcium Calculator. Even if I were 45, I'd be at the 89th percentile rank. That sounds bad. Shouldn't I do something about that now?"
Patient B: The Athlete with Family History
A 62-year-old female triathlete presents concerned about her family history of heart disease.
Patient: "My mother died of a massive heart attack at 62 so I got a screening Calcium CT scan. I was shocked when it came back at 1300! I'm really scared but I don't want to take any drugs. I prefer a natural approach."
Cardiologist: "I don't believe in those scores. There's never been a randomized controlled trial showing any benefit to a calcium score. Are you having any symptoms?"
CardioAdvocate Note: Both patients received inadequate guidance. Patient A has high lifetime risk despite a "low" absolute score. Patient B has severely elevated risk equivalent to heart attack survivors — and now we have RCT evidence from CAUGHT-CAD that CAC-guided treatment works.
Flying Under the Radar
Low CAC Scores That Fail to Receive Appropriate Treatment
While a low calcium score may impart low short-term risk in an elderly patient, it may represent high lifetime risk in a young person (>75th percentile for age, gender, race), placing them on a high-risk trajectory for ASCVD complications over the next 30 years.
CAC scores carry a "warranty" of about 5-10 years for near-term risk. But when compared to others of the same age, gender, and race, the percentile rank informs upon "lifetime" or 30-year risk.
Risk Calculators Miss the Mark in Familial CAD
The CAUGHT-CAD trial enrolled 695 asymptomatic, intermediate-risk adults aged 40–70 with family history of premature CAD from 7 hospitals across Australia. Key insights about risk calculator limitations:
- Conventional risk calculators (like the PREVENT equations) are highly age-dependent and may underestimate lifetime risk in younger adults with family history
- A randomized feasibility trial (Muhlestein et al., JACC Cardiovasc Imaging 2022) showed CAC-guided statin allocation outperforms pooled cohort equations alone
- Despite being classified as "intermediate risk" by calculators, CAUGHT-CAD participants had significant plaque burden detectable only by imaging
- CAC-guided intervention reduced plaque progression (15.4 vs. 24.9 mm³) — proving calculators alone miss actionable disease
High CAC Scores That Fail to Receive Aggressive Treatment
After decades of controversy (Watch "The Widowmaker"), multiple guidelines have finally embraced coronary artery calcium scores for ASCVD risk stratification. Yet many providers remain unconvinced, still holding out for an RCT.
That RCT now exists. The CAUGHT-CAD trial demonstrated that CAC-guided intervention reduces plaque progression (15.4 vs. 24.9 mm³) compared to standard care.
Long-standing endurance athletes have been identified as a subgroup with a predilection for higher CAC scores, which may partly explain sudden cardiac death during endurance races. See "Killer Workouts - The Adult Athlete."
CardioAdvocate Checklist
When to Consider CAC Screening
CAC Score Interpretation Table
| CAC Score | Classification | 10-Yr Event Rate | Clinical Action |
|---|---|---|---|
| 0 | None | 1.1–1.7% | Statins may be withheld (except smokers, DM, strong FHx). Warranty ~5–7 yrs. |
| 1–99 | Mild | 2.3–5.9% | Favors statin therapy, especially if age >55 or high percentile. |
| 100–299 | Moderate | 12.8–16.4% | Statin indicated. Target LDL-C <70 mg/dL. Consider secondary prevention. |
| ≥300 | Severe | 9% over 4 yrs | Risk = heart attack survivors (CONFIRM Registry). Secondary prevention: target LDL-C <55. |
| >400 | Very High | 22.5–28.6% | Consider stress testing. Aggressive risk factor modification. |
| >1000 | Extreme | 37% | Maximum secondary prevention. LDL-C <40, ApoB <50 mg/dL. |
Colors indicate escalating cardiovascular risk: Green = low risk, Yellow = mild, Orange = moderate, Light red = severe, Red = very high, Dark red = extreme.
- Percentile Rank ≥75th: Statin indicated regardless of absolute score — this indicates high lifetime risk.
- Anyone under age 50 with CAC >0: Represents high lifetime risk — intervention warranted.
Questions to Ask Your Clinician
- "My risk calculator says I'm low risk, but I have strong family history. Should I get imaging to see what's actually in my arteries?"
- "Do these risk scores account for my family history of premature heart disease?"
- "Would a coronary calcium score or CT angiogram give us a better picture of my actual risk?"
- "What percentile am I compared to others my age — not just the absolute number?"
- "Given the new CAUGHT-CAD trial data, shouldn't we use my CAC score to guide treatment intensity?"
- "My CAC score is over 300 — should I be treated like someone who already had a heart attack?"
Deep Dive: Understanding CAC
What is a CAC CT Scan?
It's a non-contrast computed tomography (CT) scan using MDCT (previously EBT) with high-resolution gated imaging to search for and quantify coronary artery calcium (CAC) deposits.
How Does a CAC Test Help with Risk Assessment?
CAC provides independent incremental information for predicting all-cause mortality in addition to traditional risk factors. Dr. Arthur Agatston first described this technology in 1990, publishing the original method for quantifying coronary artery calcium using ultrafast computed tomography.
The Power of Zero
A concept championed by Dr. Matthew Budoff: a CAC score of 0 imparts very low short-term cardiovascular risk and can be used to "de-risk" individuals, potentially deferring statin therapy in select patients. In MESA, approximately 50% of asymptomatic adults had a CAC score of 0, with 10-year event rates of 1.1-1.7% (Budoff et al., Eur Heart J 2018).
The NNT for CAC >100 is 12 (you only need to treat 12 people to prevent one event). The NNT for CAC 0 is 3,571 — essentially no meaningful benefit from statin therapy in those without detectable coronary calcium. (Mitchell et al., JACC 2018)
In the absence of diabetes, active smoking, or family history of premature ASCVD, statin therapy in those with CAC = 0 is associated with limited expected benefit (NLA Scientific Statement). But this is 10-year risk. If lifetime (30-year) risk is high, guidelines recommend early intervention.
CAC Warranty Period
Recommended repeat screening intervals (NLA Scientific Statement; Dzaye et al., JACC Cardiovasc Imaging 2021):
- CAC = 0, Low risk (<5%): 5-7 years
- CAC = 0, Borderline-intermediate risk (5-19.9%): 3-5 years
- CAC = 0, High risk or diabetes: 3 years
- CAC 1-99: 3-5 years if results might change treatment
- CAC 100-299: 3 years to assess for accelerated progression (>20-25%/year)
What Does Calcification Represent?
- Coronary artery calcification is pathognomonic for coronary atherosclerosis
- Calcification occurs even at early stages of plaque development
- Calcification represents about 20% of overall plaque volume
- Calcification is the byproduct of plaque inflammation
- Where calcification exists, inflammation has existed and is likely ongoing
- Higher calcification = higher degree of inflamed atherosclerotic plaque
- Anyone <50 years with CAC >0 has high lifetime risk
- Calcification is not the target of therapy — the inflamed plaque adjacent to it is
- Statins increase CAC score by increasing plaque density as "plaque stabilization" ensues — this is a good thing
Do I Need Aspirin?
MESA demonstrated that in those free of diabetes, CAC = 0 predicted net harm with aspirin, while CAC >100 predicted net benefit regardless of risk factors. (Cainzos-Achirica et al., Circulation 2020)
2026: The Year CAC-Guided Prevention Got Its RCT Evidence
CAUGHT-CAD Trial: First RCT Showing CAC-Guided Intervention Affects Plaque Outcomes
Study Design
Randomized controlled trial (JAMA 2025) comparing CAC-guided intervention (knowledge of CAC score + lifestyle modification + statin therapy) vs. standard care in 695 asymptomatic patients with family history of CAD.
Key Finding
CAC-guided intervention reduced plaque progression on CCTA: 15.4 mm³ vs. 24.9 mm³ in the standard care group.
Why This Matters
This is the first RCT to demonstrate that knowing your CAC score and acting on it changes plaque trajectory. For decades, skeptics demanded an RCT — now we have one.
Expert Signal: Matthew Budoff continues to lead CAC progression research.
AHA Scientific Statement: Opportunistic CAC Detection
The AHA has published a scientific statement on opportunistic CAC detection (Circulation 2025) from non-cardiac CT scans. If CAC is incidentally seen on a chest CT done for another reason, it should be reported and acted upon — not ignored.
CardioAdvocate Phenotype Opportunity
The patient with family history and intermediate risk who gets CAC scored and changes trajectory is the prototypical CardioAdvocate success story. Also relevant: the "CAC zero warranty period" discussion — understanding when zero is truly reassuring vs. when it needs repeat testing.
Expert Sources
- Matthew Budoff, MD — Leading CAC progression researcher, PI of CAUGHT-CAD
- Thomas Marwick, MD — Senior author on risk calculator study, PI of CAUGHT-CAD
- Stephen Nicholls, MD — Leading lipid/imaging researcher
- Gerald Watts, MD — Familial hypercholesterolemia expert
- Arthur Agatston, MD — The Agatston Center
Key References
- Muhlestein et al. Coronary Artery Calcium Versus Pooled Cohort Equations Score for Primary Prevention Guidance: Randomized Feasibility Trial. JACC Cardiovasc Imaging 2022
- Khan et al. Novel Prediction Equations for Absolute Risk Assessment of Total CVD (PREVENT). Circulation 2023
- Nerlekar et al. Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease (CAUGHT-CAD). JAMA 2025
- Orringer et al. The National Lipid Association Scientific Statement on Coronary Artery Calcium Scoring. J Clin Lipidol 2021
- Gaine et al. Coronary Artery Calcium Score as a Graded Decision Tool. JACC Advances 2023
- When Does a Calcium Score Equate to Secondary Prevention? Insights from the Multinational CONFIRM Registry. JACC Cardiovasc Imaging 2023
- AHA Scientific Statement: Opportunistic Detection of Coronary Artery Calcium on Noncardiac Chest CT. Circulation 2025
- Budoff et al. Ten-year Association of Coronary Artery Calcium with ASCVD Events (MESA). Eur Heart J 2018
- Mitchell et al. Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring. JACC 2018
- Cainzos-Achirica et al. Coronary Artery Calcium for Personalized Allocation of Aspirin (MESA). Circulation 2020
- Dzaye et al. Warranty Period of a Calcium Score of Zero (MESA). JACC Cardiovasc Imaging 2021
- Budoff MJ. The True Power of Zero. JACC Cardiovasc Imaging 2023
- Agatston et al. Quantification of Coronary Artery Calcium Using Ultrafast Computed Tomography. JACC 1990
- MESA Calcium Calculator
